Table 3. Mean serum concentrations (μM) of amino acids, amino acid derivatives, and ammonium compounds determined by DI-MS in overweight cats (n = 14) receiving control (no additional choline supplementation, 1.2 x NRC RA, 77 mg/kg BW0.67), choline at 2 x NRC RA (126 mg/kg BW0.67), 4 x NRC RA (252 mg/kg BW0.67), 6 x NRC RA (378 mg/kg BW0.67), and 8 x NRC RA (504 mg/kg BW0.67), in a 5 x 5 Latin square design for 3-week periods.
Choline Dose | ||||||
---|---|---|---|---|---|---|
Control | 2 x NRC RA | 4 x NRC RA | 6 X NRC RA | 8 X NRC RA | PDose | |
Amino Acids | ||||||
Alanine | 443.89 ± 48.10 | 459.87 ± 48.54 | 477.19 ± 49.19 | 543.70 ± 56.04 | 512.11 ± 52.79 | 0.350 |
Arginine | 162.25 ± 8.03b | 177.01 ± 7.84ab | 179.34 ± 7.68ab | 180.43 ± 7.68ab | 187.43 ± 7.68a | 0.039 |
Asparagine | 47.15 ± 3.85ab | 45.30 ± 3.81b | 52.66 ± 3.77a | 53.55 ± 3.77a | 53.81 ± 3.77a | 0.003 |
Aspartic acid | 62.61 ± 8.52 | 65.30 ± 8.34 | 69.08 ± 8.19 | 75.92 ± 8.19 | 75.56 ± 8.19 | 0.308 |
Citrulline | 22.73 ± 1.59 | 23.61 ± 1.56 | 25.18 ± 1.53 | 25.51 ± 1.53 | 24.33 ± 1.53 | 0.266 |
Glutamic acid | 93.92 ± 14.73 | 111.36 ± 14.64 | 105.75 ± 14.55 | 104.25 ± 14.55 | 95.86 ± 14.55 | 0.311 |
Glutamine | 740.68 ± 37.34 | 694.80 ± 36.52 | 755.70 ± 35.80 | 696.03 ± 35.80 | 727.72 ± 35.80 | 0.295 |
Glycine | 336.20 ± 14.64 | 348.06 ± 14.27 | 360.79 ± 13.94 | 368.74 ± 13.94 | 360.14 ± 13.94 | 0.222 |
Histidine | 106.29 ± 3.33 | 107.62 ± 3.22 | 115.98 ± 3.11 | 117.20 ± 3.11 | 117.01 ± 3.11 | 0.014 |
Homocysteine | 8.28 ± 0.31ab | 7.81 ± 0.29ab | 8.07 ± 0.28ab | 8.75 ± 0.28a | 7.52 ± 0.28b | 0.019 |
Isoleucine | 55.18 ± 3.08 | 55.69 ± 3.02 | 56.22 ± 2.97 | 56.22 ± 2.97 | 57.13 ± 2.97 | 0.965 |
Leucine | 113.00 ± 6.43 | 112.00 ± 6.29 | 114.90 ± 6.18 | 114.82 ± 6.18 | 116.98 ± 6.18 | 0.922 |
Lysine | 152.50 ± 8.19b | 164.75 ± 8.01ab | 175.50 ± 7.85a | 170.68 ± 7.84ab | 181.56 ± 7.85a | 0.006 |
Methionine | 43.45 ± 2.24b | 45.10 ± 2.20bc | 49.68 ± 2.17ac | 50.37 ± 2.17a | 49.75 ± 2.17ac | 0.001 |
Ornithine | 36.34 ± 5.34 | 33.07 ± 5.19 | 38.41 ± 5.05 | 44.29 ± 5.05 | 39.70 ± 5.05 | 0.378 |
Phenylalanine | 79.04 ± 4.17 | 83.00 ± 4.11 | 82.01 ± 4.06 | 84.37 ± 4.06 | 82.67 ± 4.06 | 0.527 |
Proline | 138.03 ± 5.90b | 139.61 ± 5.75b | 157.52 ± 5.62a | 166.10 ± 5.62a | 157.69 ± 5.62a | < 0.0001 |
Serine | 137.41 ± 6.13b | 136.99 ± 5.94b | 159.11 ± 5.79a | 165.13 ± 5.78a | 157.41 ± 5.79a | 0.0001 |
Taurine | 4.45 ± 0.19 | 4.61 ± 0.18 | 4.47 ± 0.17 | 4.65 ± 0.17 | 4.63 ± 0.17 | 0.864 |
Threonine | 112.54 ± 5.32 | 114.61 ± 5.18 | 120.02 ± 5.06 | 120.32 ± 5.06 | 124.46 ± 5.06 | 0.203 |
Tyrosine | 51.66 ± 3.23 | 49.95 ± 3.16 | 50.52 ± 3.09 | 51.80 ± 3.09 | 53.19 ± 3.09 | 0.837 |
Tryptophan | 72.56 ± 2.72 | 73.75 ± 2.64 | 70.69 ± 2.57 | 71.31 ± 2.57 | 70.35 ± 2.57 | 0.759 |
Valine | 152.13 ± 7.04 | 150.12 ± 6.92 | 157.83 ± 6.81 | 154.35 ± 6.81 | 153.76 ± 6.81 | 0.743 |
Total amino acids | 3283.34 ± 133.91 | 3390.69 ± 130.02 | 3499.44 ± 126.55 | 3604.20 ± 126.55 | 3574.06 ± 126.55 | 0.179 |
Amino Acid Derivatives | ||||||
Betaine | 252.53 ± 58.92c | 358.69 ± 56.95c | 609.81 ± 55.23b | 851.65 ± 55.23a | 816.46 ± 55.23a | < 0.0001 |
Creatine | 9.55 ± 1.23 | 9.92 ± 1.19 | 9.81 ± 1.15 | 11.09 ± 1.15 | 11.93 ± 1.15 | 0.477 |
Methylhistidine | 24.09 ± 1.33 | 23.24 ± 1.31 | 24.67 ± 1.29 | 23.82 ± 1.29 | 24.27 ± 1.29 | 0.754 |
Ammonium Compounds | ||||||
Choline | 18.98 ± 3.73 | 19.11 ± 3.66 | 22.56 ± 3.59 | 21.89 ± 3.59 | 20.77 ± 3.59 | 0.835 |
Values expressed as LSM ± SEM; Values in a row with superscripts without a common letter differ; P < 0.05, Repeated measures ANOVA with Tukey post-hoc test. DI-MS = direct infusion mass spectrometry; BW = body weight; NRC = National Research Council; RA = Recommended Allowance.